Sermorelin is promoted for muscle growth because it affects growth hormone signaling. That mechanism does not establish that a compounded prescription will produce a particular amount of muscle or improve athletic performance.
For readers over 50, the more useful question is often whether a treatment improves strength, mobility, or recovery enough to matter in ordinary life. Those outcomes require different evidence from a change in IGF-1 or a body-composition scan.
Hormone changes, lean mass, and functional strength are different outcomes. Ask which one the research actually measured.
Lean mass is not a promise of stronger muscles
A scan can classify tissue as lean without measuring its ability to generate force. A change in lean mass therefore should not be described as proof of better strength or daily function. Studies of growth hormone-related interventions have produced mixed functional findings.
Research also differs in the substances used. Somatropin, GHRH analogues, and other secretagogues should not be treated as one treatment. The HGH comparison explains why a study of hormone replacement cannot be relabeled as a study of a current sermorelin prescription.
How to evaluate a before-and-after story
A visible change can reflect exercise, nutrition, weight change, lighting, posture, other medications, or the passage of time. A photograph cannot isolate the effect of sermorelin. A testimonial also does not show how many people had little benefit or stopped because of adverse effects.
Useful evidence states the population, treatment, comparator, duration, and measured result. When those details are missing, treat the story as an account of experience rather than proof of cause. Our before-and-after guide explains how to read such examples without dismissing or overstating them.
Why a muscle-growth dose is not established by a chart
An online protocol cannot determine an appropriate dose from a training goal. It leaves out diagnosis, other medicines, the exact formulation, and the clinician's monitoring plan. Changing the amount to speed up visible results adds risk without establishing that the proposed benefit will follow.
Understand the prescription's measurements using the dosage guide, but leave dose selection to the prescriber. If you compete in organized sport, also check the anti-doping guide: medical prescribing and sports eligibility are separate questions.
Set a goal that can be reassessed
Describe the task that is difficult: climbing stairs, carrying groceries, recovering after usual activity, or returning to exercise after illness. Ask the clinician what evaluation is needed and whether nutrition, resistance exercise, rehabilitation, or another medical treatment addresses the cause.
If sermorelin is proposed, agree on a meaningful outcome and a reassessment point. A higher laboratory value alone should not become the reason to continue indefinitely. Include cost, adverse effects, and practical burden in the review. The worth-it guide offers a way to organize that decision.
Our steroid-or-peptide explanation separates drug classification from safety, prescription requirements, and sporting rules.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- Endotext: Growth Hormone and AgingExpert clinical evidence review · Separates hormone and body-composition findings from functional outcomes and long-term unknowns.
- Sigalos and Pastuszak: Safety and efficacy of growth hormone secretagoguesClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- Sinha et al.: Growth hormone secretagogues and male body compositionClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- Mayo Clinic: Sermorelin injection informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- WADA: 2026 Prohibited ListPrimary or authoritative reference · Sermorelin named under S2.2.4; rules are sport- and year-specific.
- Endocrine Society: Adult growth hormone deficiencyClinical practice guideline · Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.